Position in PFE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$122,570,969
+$40,259,239 QoQ
Shares Held
4,365,063
+32.0% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2026CallValue
$56,244,240
CallShares
2,003,000
PutValue
$24,176,880
PutShares
861,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $795,359,411 across 11 Drug Manufacturers - General names. PFE ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,233,965 | $243,362,577 | |
| 2 | BIIB |
Biogen Inc.
|
809,617 | $148,427,084 | |
| 3 | PFE |
Pfizer Inc
This page
|
4,365,063 | $122,570,969 | |
| 4 | MRK |
Merck & Co., Inc.
|
921,077 | $110,796,352 | |
| 5 | LLY |
ELI LILLY & Co
|
95,766 | $88,082,693 | |
| 6 | NVS |
Novartis AG
|
283,837 | $43,356,101 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
531,198 | $32,217,158 | |
| 8 | AMRN |
Amarin Corp Plc\Uk
|
240,761 | $3,481,404 |
All Filings in PFE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $56,244,240 | 2,003,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $122,570,969 | 4,365,063 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $24,176,880 | 861,000 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $37,803,180 | 1,518,200 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $82,311,730 | 3,305,692 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $20,208,840 | 811,600 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $4,991,532 | 195,900 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $30,614,220 | 1,201,500 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $5,548,536 | 228,900 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $29,570,376 | 1,219,900 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $28,074,186 | 1,107,900 | Call | Defined | 2025-07-21 | |
| 2024-12-31 | $18,242,028 | 687,600 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $43,052,247 | 1,622,776 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,633,142 | 609,300 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $23,657,090 | 845,500 | Call | Defined | 2024-09-16 | |
| 2024-06-30 | $19,927,356 | 712,200 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $27,372,738 | 986,405 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $24,597,600 | 886,400 | Call | Defined | 2024-05-15 | |
| 2020-06-30 | $9,307,410 | 300,000 | Call | Defined | 2020-08-14 | |
| 2020-03-31 | $54,028,571 | 1,744,675 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||